New York, United States, 2022-Apr-11 — /EPR Network/ — The global Indolent Lymphoma Treatment Market is on the verge of witnessing a drastic In Upcoming [read full press release…]
San Jose, USA, 2019-Aug-01 — /EPR Network/ — AbboMax, Inc has developed the panels of antibodies to study B- and T-cell lymphomas. Lymphoma is a [read full press release…]
Albany, USA, 2019-Jan-28 — /EPR Network/ — Growing burden of cancer prevalence round the globe has maneuvered significant advances in cancer therapeutics development market in [read full press release…]
Albany, US, 2018-Nov-06 — /EPR Network/ — Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T [read full press release…]
Dublin 2, Ireland, 2018-Jan-25 — /EPR Network/ — The Fact.MR report offers majority of the latest and newest industry data that covers the overall market [read full press release…]
Albany, US, 2017-Nov-17 — /EPR Network/ —Based on Myc Proto Oncogene Protein H2 2017, a research study is published titled “Myc Proto Oncogene Protein (Transcription Factor [read full press release…]
